18 May 2013
Keywords: quadrant, drops, lead, compound, healthcare, dropped, development
Article | 08 October 1998
Quadrant Healthcare has dropped the development of one of its lead drugdevelopment candidates, a version of Glaxo Wellcome's antiviral drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.